Ventyx Biosciences Stock (NASDAQ: VTYX) stock price, news, charts, stock research, profile.
Open | $4.320 |
Close | - |
Volume / Avg. | 186.076K / 3.931M |
Day Range | 4.220 - 4.450 |
52 Wk Range | 1.865 - 40.580 |
Market Cap | $303.852M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 18.19% |
Days to Cover | 6.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ventyx Biosciences (NASDAQ: VTYX) through any online brokerage.
Other companies in Ventyx Biosciences’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and Xeris Biopharma Holdings (NASDAQ:XERS).
The latest price target for Ventyx Biosciences (NASDAQ: VTYX) was reported by Canaccord Genuity on Wednesday, March 13, 2024. The analyst firm set a price target for 15.00 expecting VTYX to rise to within 12 months (a possible 248.03% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Ventyx Biosciences (NASDAQ: VTYX) is $4.31 last updated April 23, 2024 at 7:52 PM EDT.
There are no upcoming dividends for Ventyx Biosciences.
Ventyx Biosciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Ventyx Biosciences.
Ventyx Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.